NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
HOUSTON, Nov. 27, 2023 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospital facilities in 8 states and primary care-centric, risk-bearing physician networks, today announced that it has received a letter from Nasdaq granting it an additional 180-day extension, or until May 20, 2024, to evidence compliance with Nasdaq’s $1.00 minimum bid requirement.
Related news for (NUTX)
- NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
- NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION
- Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call
- NUTEX HEALTH TO RING NASDAQ BELL AND MEET WITH INVESTORS IN NYC ON AUGUST 26
- Nutex Health Responds to Short Seller Report